- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Omkar Pharmachem has clarified a delay in reporting the departure of Independent Director Mr. Janak Raj Sharma, whose two five-year terms concluded on February 12. The company filed the necessary intimation on February 14, explaining they waited for the Board of Directors to officially note the change at their meeting first. This update explains a procedural delay in disclosing a significant governance change, underscoring the company's focus on compliance and transparent communication about its board.